Reactive arthritis, diagnosis and treatment

Acta Orthopaedica

Volumn 67, Issue 2, 1996, Pages 196-201

  Nordstrom, Dan C E ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIRHEUMATIC AGENT; AZATHIOPRINE; CEFTRIAXONE; CYCLOPHOSPHAMIDE; GOLD; HLA B27 ANTIGEN; LYMECYCLINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; TETRACYCLINE;

ARTICULAR CARTILAGE; COLLAGEN DEGRADATION; DISEASE COURSE; ENTERITIS; HUMAN; IMMUNOREGULATION; INFECTION; INTRAMUSCULAR DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PROGNOSIS; REACTIVE ARTHRITIS; REVIEW;

ARTHRITIS, REACTIVE; HUMANS;

EID: 0029873878     PISSN: 17453674     EISSN: 17453682     Source Type: Journal    
DOI: 10.3109/17453679608994673     Document Type: Article

References (42)

1. Aho K, Ahvonen P, Lassus A, Sievers K, Tiilikainen A. HLA 27 in reactive arthntis. Lancet 1973; 2: 157.
2. Ahvonen P, Sievers K, Aho K. Arthritis associated with Yersinia enterocolitica infection. Acta Rheumatol Scand 1969; 15: 232-52.
3. Calin A. A placebo-controlled, crossover study of azathioprine in Reiter's syndrome. Ann Rheum Dis 1986; 45: 653-6.
4. Caperton E M, Heim-Duthoy K L, Matzke G R, Peterson P K, Johnson R C. Ceftriaxon therapy of chronic inflammatory arthritis. A double-blind, placebo-controlled trial. Arch Intern Med 1990 150: 1677-80.
5. Chee Y C, Chan H L. Reiter's disease, responding to methotrexate. Sing Med J 1977; 18: 136-8. (Pubitemid 8211755)
6. Egsmose C, Hansen T M, Andersen L. Sulfasalazine in the treatment of reactive arthritis. A 6-month, placebo-controlled trial. Rev Esp Rheumatol (Suppl 1) 1993; 20: 490-9.
7. Farber G A, Forshner J G, O'Quinn 0 J. Reiter's syndrome, treatment with methotrexate. JAMA 1967; 200: 181-3.
8. Fryden A, Bengtsson A, Foberg U, Svenungsson B, Castor B, Kärnell A, Scharz R, Lindblom B, Kihlström E. Early antibiotic treatment of reactive arthritis associated with enteric infections, clinical and serological studies. Br Med J 1990; 30: 1299-1302.
9. Gabler W L, Creamer H R. Suppression of human neutrophil functions by tetracyclines. J Periodont Res 1991: 26: 52-8.
10. Granfors K, Jalkanen S, von Essen R, Lahesmaa-Rantala R, Isomäki O, Pekkola-Heino K, Merilahti-Palo R, Saario R, Isom̈ki H, Toivanen A. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med 1989: 320: 216-21. (Pubitemid 19034147)
11. Granfors K, Jalkanen S, Lindberg A A, Mäki-Ikola O, von Essen R, Lahesmaa-Rantala R, Isomäki H, Saario R, Arnold W J, Toivanen A. Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet 1990; 335: 685-8. (Pubitemid 20089308)
12. Keat A. ABC of rheumatology: Spondylarthropdthies. Br Med J 1995; 310: 1321-4.
13. Keat A, Thomas B, Dixey J, Osbom M, Sonnex C, Taylor- Robinson D. Chlamydia trachomatis and reactive arthritis: the missing link. Lancet 1987; 1: 72-4. (Pubitemid 17015775)
14. Kingsley G H. Reactive aahrtis: a paradigm for inflammatory arthritis. Clin Exp Rheumatol (Supp1 8) 1993; 11 : 29-36.
15. Konttinen Y T, Nordstrom D, Bergroth V, Leirisalo-Repo M, Santavirta S. Occurrence of different ensuing triggering infections preceding reactive arthritis: a follow-up study. Br Med J 1988; 296: 1644-5.
16. KonttinenYT, Lindy O, Suomalainen K, Ritchlin C, Saari H, Vauhkonen M, Lauhio A, Santavirta S, Sorsa T. Substrate specificity and activation mechanisms of collagenase from human rheumatoid synovium. Matrix 1991; 11: 395-403.
17. Kortekangas P. Bacterial arthritis of the adult knee joint. Thesis. Annales Universitatis Turkuensis 1994; 155: 1-103.
18. Lahesmaa-Rantala R, Granfors K, Isomäki H, Toivanen A. Yersinia-specific immune complexes in the synovial fluid of patients with Yersinia-triggered reactive arthritis. Ann Rheum Dis 1987; 46 510-4. (Pubitemid 17091272)
19. Lally E V, Ho G Jr. A review of methotrexate therapy in Reiter's syndrome. Semin Arthritis Rheum 1985; 15: 139-45. (Pubitemid 16215433)
20. Lauhio A, Leirisalo-Repo M, Lahdevirka J, Saikku P, Repo H. Double-blind, placebo-controlled study of a threemonth treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum 1991; 34: 6-14.
21. Lauhio A, Sorsa T, Lindy O, Suomalainen K, Saari H, Golub LM, Konttinen YT. The anticollagenolytic potential of lymecyclin in the long-term treatment of reactive arthritis. Arthritis Rheum 1992; 35: 195-8.
22. Lauhio A, Nordstrom D, Sorsa T, Saa.ri H, Rose S, Lindy O, Golub L, Konttinen Y T. Long-term treatment of reactive arthritis with tetracycline. In: Progress in Rheumatology (Ed. Machtey I). Rheumatology Service, Golda Medical Center, Petah Tiqua 1994a; 5: 84-9.
23. Lauhio A, Konttinen Y T, Tscheche H, Nordström D, Salo T, L̈devirta J, Golub L, Sorsa T. Reduction of matrix metalloproteinase 8-neutrophil collagenase levels during long-term doxycycline treatment of reactive arthritis. Antimicrob Agents Chemoter 1994b; 38: 400-2. (Pubitemid 24054275)
24. Leirisalo-Repo M. Reactive complications to gastrointestinal infections. Finska Läkaressällskapets Handlingar 1992; 1: 28-33.
25. Miehke K, Kafamik U. Klinische Erfarungen mit Isophosphamid der Behandlung der chronische Polyarthritis. Verh Dtsch Ger Rheumat (Suppl 2) 1972; 2: 415-9.
26. Mielants H, Veys E M. HLA-B27 related arthritis and bowel inflammation. Part 1. Sulfasalazine in HLA-B27-related reactive arthritis. J Rheumatol 1985; 12: 287-93. (Pubitemid 15025371)
27. Mielants H, Veys E M, Goemaere S. A prospective study of patients with spondylarthropathy with special reference to HLA-B27 and to gut history. J Rheumatol 1993; 20: 1353-8. (Pubitemid 23310989)
28. Nordström D. DNA synthesis in CD4- and CD8-positive cells in synovial fluid of patients with reactive and rheumatoid arthritis. Rheumatol Int 1989a; 8: 269-72.
29. Nordström D. Cellular inflammation in arthritis. A study of immunological, clinical and immunological aspects in rheumatoid and reactive arthritis. Thesis. Comm Phys- Math 1989b; 105: 1-120.
30. Nordström D, Konttinen Y T. Reactive arthritis: an update. Biomed Pharmacother 1989; 43: 737-42. (Pubitemid 20093559)
31. Panayi G S, Clark B. Minocycline in the treatment of patients with Reiters's syndrome. Clin Exp Rheumatol 1989; 7: 100-1. (Pubitemid 19086252)
32. Paulus H E, Pearson C M, Pitts W. Aortic insuffiency in five patients with Reiter's syndrome. A detailed clinical and pathological study. Am J Med 1972; 142: 467-9.
33. Pott H G, Witterborg A, Junge-Hulsing G. Long-term antibiotic treatment in reactive arthritis. Lancet 1988; 1: 245-6. (Pubitemid 18044060)
34. Schumacher H R Jr, Magge S, Cheridan P V, Sleckman J, Rothfuss S, Claybume G, Sieck M. Light and electron microscopic studies on the synovial membrane in Reiter 's syndrome. Arthritis Rheum 1988; 31: 937-46.
35. Sieper J, Kingsley G, Palacios-Boix A, Pitzalis C, Treharne J, Keat A, Panayi G S. Synovial T lymphocyte-specific immune response to Chlamydia trachomatis in Reiter 's syndrome. Arthritis Rheum 1991; 3 4 588-98.
36. Taylor-Robinson D. Gilroy C B, Thomas B J, Keat A C. Detection of Chlamydia trachomatis DNA in joints of reactive arthritis patients with polymerase chain reaction. Lancet 1992; 340 81-2.
37. Toivanen A, Yli-Kerttula T, Luukkainen R, Merilahti-Palo R, Granfors K, Seppälä J. Effect of antimicrobial treatment on chronic reactive arthritis. Clin Exp Rheumatol 1993; 11: 301-7. (Pubitemid 23236133)
38. Trnavsky K, Peliskova Z, Vacha J. Sulfasalazine in the treatment of reactive arthritis. Scand J Rheumatol 1988; 67: 16-9.
39. Wasil M, Halliwell B, Moonhouse C P. Scavenging of hypoclorous acid by tetracycline, rifampicin and some other antibiotics: a possible antioxidant action of rifampicin and tetracycline. Biochem Pharmacol 1981; 37: 775-84.
40. Wordswoth B P, Hughes R A, Allan l, Kedt A C, Bell J I. Chlamydia1 DNA is absent from the joints of patients with sexually-acquired reactive arthritis. Br J Rheumatol 1990; 29: 208-10. (Pubitemid 20194023)
41. Ziedler H. Rheumatologists confirm role of Chlamydia in arthritis. Cum Antibiot Ther 1992.
42. Zwillich S H, Comer S S, Lee E. Treatment of the seronegative spondylarthropathies with sulfasalazine. J Rheumatol (Suppl 16) 1988; 15: 33-9.